Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A diabetes and drug technology, applied in the field of medicine, can solve the problems of large fluctuations in blood sugar and urine sugar concentration, small reduction in blood sugar and urine sugar, and inability to take care of diabetic patients, so as to achieve blood sugar reduction, blood sugar and urine sugar reduction. Effect
Pending Publication Date: 2016-06-08
徐宝贞
View PDF6 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0010] (1) It has no obvious effect on lowering blood sugar;
[0011] (2) The degree of reduction in blood sugar and urine sugar is small, and it cannot take into account diabetic patients of different ages;
[0012] (3) After stopping the drug, the blood sugar and urine sugar concentration fluctuate greatly
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0037] Embodiment 1 A kind of medicine for treating diabetes
[0038] The drug is marine algae glycoprotein;
[0039] Said marine algae glycoprotein, by weight content, comprises sugar 1%, protein 99%,
[0040] The molecular weight is 0.2kDa;
[0041] The marine algae are: cyanobacteria;
[0042] The sugar is a polysaccharide;
[0043] The polysaccharides include: glucose, mannose, rhamnose, galactose;
[0044] The protein includes: aspartic acid, glutamic acid, glycine, arginine, lysine, serine, threonine.
Embodiment 2
[0045] Embodiment 2 A kind of medicine for treating diabetes
[0046] The drug is marine algae glycoprotein;
[0047] Said marine algal glycoprotein, by weight content, comprises sugar 8%, protein 80%,
[0048] The molecular weight is 10kDa;
[0049] The marine algae is: green algae;
[0050] The sugar is a polysaccharide;
[0051] The polysaccharides include: glucose, mannose, rhamnose, galactose;
[0052] The protein includes: aspartic acid, glutamic acid, glycine, arginine, lysine, serine, threonine.
Embodiment 3
[0053] Embodiment 3 A kind of medicine for treating diabetes
[0054] The drug is marine algae glycoprotein;
[0055] Said marine algae glycoprotein, by weight content, comprises sugar 15%, protein 70%,
[0056] The molecular weight is 5kDa;
[0057] The marine algae are: cyanobacteria;
[0058] The sugar is a polysaccharide;
[0059] The polysaccharides include: glucose, mannose, rhamnose, galactose;
[0060] The protein includes: aspartic acid, glutamic acid, glycine, arginine, lysine, serine, threonine.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
molecular weight
aaaaa
aaaaa
molecular weight
aaaaa
aaaaa
molecular weight
aaaaa
aaaaa
Login to view more
Abstract
The invention provides medicine used for treating diabetes mellitus and complications thereof. The medicine is glycoprotein, or a mixture of polysaccharide and protein, or polypeptide or protein. The medicine has an obvious effect of reducing blood glucose of a rat diabetes model, and in the four weeks after the medicine is taken, the blood glucose of a rat is reduced from 27.06-27.19 mmol / L to 11.26-23.41 mmol / L. The medicine is used for treating diabetes mellitus continuously for four weeks, the result shows that a blood glucose value can be reduced obviously, the content of urine protein and the content of urea nitrogen in serum are reduced, the content of triglyceride in the serum is reduced, and the thymus indexes of the rat are increased. The medicine has the obvious effect of reducing the blood glucose and urine sugar of patients with the diabetes mellitus; meanwhile, the medicine has a function of adjusting hyperglycemia, hypertension, hyperlipidemia and high blood viscosity threatening the diabetes mellitus severely. The medicine has the advantages of being safe, efficient and free of side effects, and has the obvious effects of reducing the blood glucose, cholesterol and triglyceride.
Description
technical field [0001] The invention relates to a medicine for treating diabetes and belongs to the technical field of medicine. Background technique [0002] Diabetes mellitus is a chronic, metabolic disease characterized by hyperglycemia caused by defective insulin secretion or its biological action, or both. Diabetes is incurable and associated with several other diseases. It is the leading cause of blindness in people aged 25-74. 10% of diabetic patients are complicated with kidney disease. Diabetes is the most common cause of non-traumatic lower extremity amputation. There is a 30-fold increased risk of resection, a 2-4-fold increased risk of heart disease in diabetics, and a 5-fold increased risk of stroke. [0003] The cause of diabetes is unknown, but both genetic and environmental factors appear to play a role. There are two types of diabetes: insulin-dependent (type I) and non-insulin-dependent (type II). [0004] Type 1 diabetes is an autoimmune disease that of...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more